Stoke Therapeutics (STOK)'s 30-day implied volatility (IV30) was 47.3% at the close on November 13, 2026, down from 52.2% the day before, against a 52-week range of 36.9% to 126.6%. Its 20-day historical volatility was 57.6%.
Data as of November 13, 2026.